Mitochondrial Dysfunction in HFpEF: Potential Interventions Through Exercise
- PMID: 39863753
- DOI: 10.1007/s12265-025-10591-5
Mitochondrial Dysfunction in HFpEF: Potential Interventions Through Exercise
Abstract
HFpEF is a prevalent and complex type of heart failure. The concurrent presence of conditions such as obesity, hypertension, hyperglycemia, and hyperlipidemia significantly increase the risk of developing HFpEF. Mitochondria, often referred to as the powerhouses of the cell, are crucial in maintaining cellular functions, including ATP production, intracellular Ca2+ regulation, reactive oxygen species generation and clearance, and the regulation of apoptosis. Exercise plays a vital role in preserving mitochondrial homeostasis, thereby protecting the cardiovascular system from acute stress, and is a fundamental component in maintaining cardiovascular health. In this study, we review the mitochondrial dysfunction underlying the development and progression of HFpEF. Given the pivotal role of exercise in modulating cardiovascular diseases, we particularly focus on exercise as a potential therapeutic strategy for improving mitochondrial function. Graphical abstract Note: This picture was created with BioRender.com.
Keywords: Exercise; Heart failure with preserved ejection fraction; Mitochondria; Mitochondrial dynamics; Oxidative stress.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Disclosures: Dr. Junjie XIAO is an associate editor of Journal of Cardiovascular Translational Research. Dr. Lijun Wang is an editorial board member of Journal of Cardiovascular Translational Research. The other authors declare no competing interests. Ethics Approval and Consent to Participate: Not applicable. Informed Consent: Not applicable.
Similar articles
-
Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction.Circulation. 2019 Mar 12;139(11):1435-1450. doi: 10.1161/CIRCULATIONAHA.118.036259. Circulation. 2019. PMID: 30856000 Free PMC article. Review.
-
Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose.BMC Cardiovasc Disord. 2018 Apr 2;18(1):57. doi: 10.1186/s12872-018-0796-2. BMC Cardiovasc Disord. 2018. PMID: 29606104 Free PMC article.
-
Mitochondrial Morphology, Dynamics, and Function in Human Pressure Overload or Ischemic Heart Disease With Preserved or Reduced Ejection Fraction.Circ Heart Fail. 2019 Feb;12(2):e005131. doi: 10.1161/CIRCHEARTFAILURE.118.005131. Circ Heart Fail. 2019. PMID: 30744415
-
Blunted Cardiac Mitophagy in Response to Metabolic Stress Contributes to HFpEF.Circ Res. 2024 Oct 25;135(10):1004-1017. doi: 10.1161/CIRCRESAHA.123.324103. Epub 2024 Sep 27. Circ Res. 2024. PMID: 39328167
-
In the heart and beyond: Mitochondrial dysfunction in heart failure with preserved ejection fraction (HFpEF).Curr Opin Pharmacol. 2024 Jun;76:102461. doi: 10.1016/j.coph.2024.102461. Epub 2024 May 16. Curr Opin Pharmacol. 2024. PMID: 38759430 Free PMC article. Review.
Cited by
-
Advances in pathophysiological mechanisms and therapeutic efficacy of exercise rehabilitation in patients with heart failure with preserved ejection fraction.Front Cardiovasc Med. 2025 May 27;12:1598878. doi: 10.3389/fcvm.2025.1598878. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40495991 Free PMC article. Review.
-
Mechanisms of exercise intolerance in heart failure with preserved ejection fraction (HFpEF).Heart Fail Rev. 2025 Jul;30(4):777-789. doi: 10.1007/s10741-025-10504-3. Epub 2025 Mar 13. Heart Fail Rev. 2025. PMID: 40080287 Free PMC article. Review.
-
Coronary microvascular disease in heart failure with preserved ejection fraction.Physiol Rep. 2025 Aug;13(16):e70521. doi: 10.14814/phy2.70521. Physiol Rep. 2025. PMID: 40834289 Free PMC article. Review.
References
-
- Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res. 2023;118:3434–50. - PubMed
-
- Wu C, Zhang Z, Zhang W, Liu X. Mitochondrial dysfunction and mitochondrial therapies in heart failure. Pharmacol Res. 2022;175:106038. - PubMed
-
- Qiu Y, Fernandez-Garcia B, Lehmann HI, Li G, Kroemer G, Lopez-Otin C, Xiao J. Exercise sustains the hallmarks of health. J Sport Health Sci. 2023;12:8–35. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous